A new paradigm has emerged to utilize RNA-based molecular machines as sensors to regulate new gene networks and as therapeutics to treat diseases such as HIV and breast cancer. These biomolecular machines harness RNA's extraordinary ability to adopt complex 3D shapes, perform catalysis, and change shapes in response to cellular and viral molecules. Furthermore, RNA can be produced in large quantities using established synthesis and can be coupled to increasingly facile cellular delivery methods. Unfortunately, despite RNA's potential as a design medium, development of RNA-based therapeutics and sensors are significantly hindered by inaccurate models of RNA folding and design, necessitating time-consuming selection methods and trial-and-error refinement. To accelerate the generation of RNA-based technology, I have developed RNAMake, the first automated RNA 3D design toolkit. RNAMake utilizes RNA motifs, the building blocks of RNA 3D structure which, in a few cases, have been shown to be modular. I propose to resolve current barriers to automate the design of RNA-based therapeutics through the following aims: First exhaustively characterizing the modularity of all known motifs by testing them in 3D design problems to generate a curated database of highly modular building blocks, increasing the confidence in RNAMake's designs and second to demonstrate RNAMake's straightforward approach to developing a novel RNA-based sensors to detect mir129, mir212, mir21, and mir208a miRNAs which are critical indicators of hypertrophic cardiomyopathy (HCM). In both of these aims, I will evaluate success through using a combination of massively parallel SHAPE chemical mapping, selective crystallography (Jeffrey Kieft), FRET measurements (William Greenleaf) and cell culture based assays (Euan Ashley). This proposal is highly collaborative, bringing together experiments a wide variety of fields including Structural Biology, Genetics and Medicine. Successful completion of the aims set forth, will yield the first detailed characterizatin of motif modularity in a publically accessible database, the first automated platform for 3D design that can be used by any RNA engineering group, and high-profile illustrations of its use for biomedically relevant RNA-based machines. In addition this work will be pursued subsequently as the focal point of my faculty career.
A new paradigm has emerged to utilize RNA-based molecular machines as sensors to regulate new gene networks and as therapeutics that have reached phase II clinical trials for the treatment of HIV and Breast cancer. Unfortunately, despite RNA's potential as a design medium, development of RNA-based therapeutics and sensors are significantly hindered by inaccurate models of RNA folding and design, necessitating time- consuming selection methods and trial-and-error refinement. To accelerate the generation of RNA-based technology, I have developed RNAMake, the first automated RNA 3D design toolkit. I propose to resolve current barriers to automate the design of RNA-based therapeutics through characterizing all motifs to generate a database of highly modular building blocks increasing the confidence in RNAMake's designs and second to demonstrate RNAMake's straightforward approach to developing novel RNA-based sensors to detect mir129, mir212, mir21, and mir208a miRNAs which are critical indicators of hypertrophic cardiomyopathy (HCM).
| Yesselman, Joseph D; Tian, Siqi; Liu, Xin et al. (2018) Updates to the RNA mapping database (RMDB), version 2. Nucleic Acids Res 46:D375-D379 |
| Denny, Sarah Knight; Bisaria, Namita; Yesselman, Joseph David et al. (2018) High-Throughput Investigation of Diverse Junction Elements in RNA Tertiary Folding. Cell 174:377-390.e20 |
| Wang, Yaqiang; Yesselman, Joseph D; Zhang, Qi et al. (2016) Structural conservation in the template/pseudoknot domain of vertebrate telomerase RNA from teleost fish to human. Proc Natl Acad Sci U S A 113:E5125-34 |
| Sengupta, Raghuvir N; Van Schie, Sabine N S; Giamba?u, George et al. (2016) An active site rearrangement within the Tetrahymena group I ribozyme releases nonproductive interactions and allows formation of catalytic interactions. RNA 22:32-48 |
